Defining High-Risk Populations in Squamous Cell Anal Carcinoma

Opinion
Video

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human papillomavirus infection being the primary risk factor that is significantly amplified by immunosuppression from conditions like HIV, immunosuppressive medications or organ transplantation, particularly affecting older patients and women at higher rates.

Defining High-Risk Populations in Squamous Cell Anal Carcinoma

Squamous cell cancer of the anal canal represents a rare but increasingly significant oncological challenge, with incidence rates nearly doubling over the past three decades. This alarming trend highlights an area of substantial unmet medical need, as healthcare providers grapple with understanding and managing this uncommon malignancy. The dramatic rise in cases underscores the importance of identifying risk factors and vulnerable populations to improve prevention strategies and early detection protocols.

Human papillomavirus (HPV) infection stands as the primary and most critical risk factor for developing squamous cell anal cancer. The carcinogenic process becomes significantly amplified when HPV infection occurs alongside conditions that compromise immune function. Patients with concurrent HIV and HPV infections face a staggering 30-fold increased risk of developing anal squamous cell cancer compared with the general population. This multiplicative effect demonstrates how immunosuppression accelerates the progression from viral infection to malignant transformation.

Several patient populations face elevated risk due to chronic immunosuppressive therapy, including individuals with rheumatoid arthritis, inflammatory bowel disease and organ transplant recipients who require long-term immunosuppressive medications. Demographic factors also play a significant role, with advancing age increasing cancer risk across all populations, and women showing higher incidence rates than men. Lifestyle factors, particularly smoking, further compound the risk profile. Understanding these risk stratifications enables clinicians to implement appropriate screening protocols and preventive measures for high-risk individuals, ultimately improving outcomes through earlier detection and intervention strategies.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.